EntalpicTranslation site

Entalpic is a French artificial intelligence startup focused onChemical Materials R&Dfield, especially utilizing generative AI techniques to drive the discovery, generation, and evaluation of new materials and molecules.

Company Background and Establishment

• Established: Entalpic was founded in recent years by Mathieu Galtier, Victor Schmidt and Alexandre Duval, three French scientists with extensive academic and industrial experience in AI and machine learning. They have held key positions at Amazon and Owkin, a unicorn company in AI.
• Technical background: With a deep background in artificial intelligence and machine learning, the founding team has built an AI platform that integrates cutting-edge technologies such as Large Language Models (LLMs), active learning, and graph neural networks.

Business model and technology features

• business model: Entalpic is committed to providing innovative solutions to the chemical industry through its leading AI technology platform, driving innovation and sustainability in the industry. Its technology focuses on designing catalysts to optimize chemical processes and contribute to industrial decarbonization.
• Technical Features::
  • Generative AI: The company uses generative AI technology to discover new materials and molecules, which greatly accelerates the process of materials development.
  • automation experiment: The platform enables rapid formulation and testing of new materials and molecules in chemical hypotheses through a series of automated experiments.
  • Diversified databases: Diverse databases including numerical quantum simulations, physical laboratory experiments, academic literature and patents are integrated to provide rich data support for R&D.

Market layout and future development

• marketplace: Currently, Entalpic has operations in France, Germany and Canada, with plans to expand into the U.S. and Asian markets. This demonstrates that the company is actively seeking to expand its markets globally.
• future development: With the success of the €8.5 million seed round, Entalpic is expected to accelerate its technology development and product implementation, and further expand its market promotion. This will help enhance the company's market competitiveness and promote technological advancement in related industries.

Financing

• seed round: On September 9, 2024, Entalpic announced the closing of an €8.5 million seed round of financing. The round was led by Capita Fund, Breega and Felicis. The funding will provide strong support for the company's future R&D, marketing and business expansion.
• investor organization: In addition to the lead investor, Entalpic has received recognition and support from executives from leading companies such as Sanofi, Owkin (a CapFund portfolio company), Schrödinger, Hugging Face, Meta and Deepmind.

Industry Impact and Outlook

• Industry Impact: Entalpic's successful financing not only injected a strong impetus to its own development, but also triggered the market's extensive attention to the application of AI in the field of chemical materials research and development. As a pioneer of innovation in the industry, Entalpic is expected to promote the technological progress and industrial upgrading of the whole industry.
• development prospectEntalpic is expected to play an important role in this field and realize long-term development with its unique technical advantages and market layout.